Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: A meta-analysis of 3 randomized controlled trials

Journal of Cardiovascular Pharmacology

Volumn 64, Issue 1, 2014, Pages 41-46

  Liu, Mao ^a   Chen, Jian ^a   Huang, Dan ^a   Ke, Jianting ^a   Tang, Wenyi ^a   Wu, Wei ^a  

^a THE FIFTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

drug eluting stent; dual antiplatelet therapy; meta analysis; myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; EVEROLIMUS; ZOTAROLIMUS; RAPAMYCIN;

ACUTE CORONARY SYNDROME; BLEEDING; CEREBROVASCULAR ACCIDENT; COCHRANE LIBRARY; DEATH; DRUG ELUTING STENT; DRUG THERAPY; DUAL ANTIPLATELET THERAPY; EMBASE; EVEROLIMUS ELUTING STENT; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; INCIDENCE; LONG TERM CARE; MEDLINE; META ANALYSIS; NEOVASCULARIZATION (PATHOLOGY); NOTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT COURSE THERAPY; STENT THROMBOSIS; SYSTEMATIC REVIEW; TARGET VESSEL REVASCULARIZATION; TREATMENT DURATION; ZOTAROLIMUS ELUTING STENT; ANALOGS AND DERIVATIVES; DRUG COMBINATION; TIME;

DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; HUMANS; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SIROLIMUS; TIME FACTORS;

EID: 84904268978     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000088     Document Type: Note

References (25)

1. Colombo A, Drzewiecki J, Banning A, et al. Randomized study to assess the effectiveness of slow-and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation. 2003; 108:788Y794
2. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315Y1323
3. Kastrati A, Dibra A, Spaulding C, et al. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J. 2007;28:2706Y2713
4. Gwon HC, Hahn JY, Park KW, et al. Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study. Circulation. 2012;125: 505Y513
5. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet. 2007;369:667Y678
6. Migliorini A, Valenti R, Marcucci R, et al. High residual platelet reactivity after clopidogrel loading and long-term clinical outcome after drugeluting stenting for unprotected left main coronary disease. Circulation. 2009;120:2214Y2221
7. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61:e78Ye140
8. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet. 2001; 358:527Y533
9. Kim BK, Hong MK, Shin DH, et al. A new strategy for discontinuation of dual antiplatelet therapy: The RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimuseluting stent implantation). J Am Coll Cardiol. 2012;60:1340Y1348
10. Fajadet J, Wijns W, Laarman GJ, et al. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholineencapsulated stent for treatment of native coronary artery lesions: Clinical and angiographic results of the ENDEAVOR II trial. Circulation. 2006; 114:798Y806
11. Feres F, Costa RA, Abizaid A, et al. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: The OPTIMIZE randomized trial. JAMA. 2013;310:2510Y2522
12. Kandzari DE, Barker CS, Leon MB, et al. Dual antiplatelet therapy duration and clinical outcomes following treatment with zotarolimuseluting stents. JACC Cardiovasc Interv. 2011;4:1119Y1128
13. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Control Clin Trials. 1996;17:1Y12
14. Gasparyan AY, Watson T, Lip GY. The role of aspirin in cardiovascular prevention: Implications of aspirin resistance. J Am Coll Cardiol. 2008; 51:1829Y1843
15. Mao L, Jian C, Changzhi L, et al. Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: A metaanalysis based on 23, 035 subjects. Arch Cardiovasc Dis. 2013;106:517Y 527
16. Bernardi V, Szarfer J, Summay G, et al. Long-term versus short-term clopidogrel therapy in patients undergoing coronary stenting (from the Randomized Argentine Clopidogrel Stent [RACS] trial). Am J Cardiol. 2007;99:349Y352
17. Mulukutla SR, Marroquin OC, Vlachos HA, et al. Benefit of long-term dual anti-platelet therapy in patients treated with drug-eluting stents: From the NHLBI dynamic registry. Am J Cardiol. 2013;111:486Y492
18. Valgimigli M, Campo G, Monti M, et al. Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial. Circulation. 2012;125:2015Y2026
19. Park SJ, Park DW, Kim YH, et al. Duration of dual antiplatelet therapy after implantation of drug-eluting stents. N Engl J Med. 2010;362: 1374Y1382
20. Bryniarski L, Pelc-Nowicka A, Zabojszcz M, et al. Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies. Cardiol J. 2009;16:179Y189
21. Airoldi F, Colombo A, Morici N, et al. Incidence and predictors of drugeluting stent thrombosis during and after discontinuation of thienopyridine treatment. Circulation. 2007;116:745Y754
22. Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and longterm clinical outcomes after drug-eluting stent implantation. JAMA. 2007;297:159Y168
23. Schulz S, Schuster T, Mehilli J, et al. Stent thrombosis after drug-eluting stent implantation: Incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period. Eur Heart J. 2009;30:2714Y 2721
24. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494Y502
25. Hallas J, Dall M, Andries A, et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: Population based case-control study. BMJ. 2006;333:726